Michael A. Linden – författare

Non-Neoplastic Disorders of Bone Marrow is devoted to the evaluation and interpretation of bone marrow and peripheral blood specimens where non-neoplastic disorders can often mimic malignant conditions. Because these processes frequently require the integration of subtle morphologic clues with the clinical context, this practical, morphologically-grounded resource focuses on the spectrum of acquired non-neoplastic processes, selected clonal conditions, and congenital disorders. The volume is organized by etiology—addressing autoimmune diseases, metabolic disorders, nutritional deficiencies, and the effects of toxins and medications—to facilitate linking specific pathologic findings to potential diagnoses. By emphasizing important morphologic, immunophenotypic, genetic, and clinical features, this Fascicle fills this gap for practicing pathologists and trainees by illustrating the distinct morphologic characteristics and practical approach to the broad spectrum of benign blood and bone marrow disorders.

This textbook will provide a comprehensive, state-of-the art review the field of diagnostic hematopathology as it’s applied to patients with plasma cell neoplasms. Particular emphasis will be placed on immunophenotypic data – immunohistochemistry and flow cytometry – as well as cytogenetics. We will also discuss how these ancillary data can predict prognosis and chemotherapeutic response. Plasma Cell Neoplasms will serve as a very useful resource for physicians and researchers interested in the plasma cell myeloma diagnosis, therapy, and research. It will provide a concise yet comprehensive summary of the current status of the field that will help guide patient management and stimulate investigative efforts. All chapters will be written by experts in their fields and will include the most up to date scientific and clinical information.

This textbook will provide a comprehensive, state-of-the art review the field of diagnostic hematopathology as it’s applied to patients with plasma cell neoplasms. Particular emphasis will be placed on immunophenotypic data – immunohistochemistry and flow cytometry – as well as cytogenetics. We will also discuss how these ancillary data can predict prognosis and chemotherapeutic response. Plasma Cell Neoplasms will serve as a very useful resource for physicians and researchers interested in the plasma cell myeloma diagnosis, therapy, and research. It will provide a concise yet comprehensive summary of the current status of the field that will help guide patient management and stimulate investigative efforts. All chapters will be written by experts in their fields and will include the most up to date scientific and clinical information.